Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reactive oxygen species (ROS) generation and handling machinery encompasses the integrated network of enzymes and metabolic pathways that produce, transform, and neutralize reactive oxygen species within the cell (Sies & Jones, 2020). Primary sources of ROS include the mitochondrial respiratory chain and specialized enzymes such as NADPH oxidases (NOX), xanthine oxidase, and cytochrome P450, which generate superoxide and hydrogen peroxide as byproducts or signaling molecules (Lambeth, 2004). To prevent oxidative damage, the cell employs a robust handling system consisting of antioxidant enzymes like superoxide dismutase (SOD), catalase, and glutathione peroxidase, alongside non-enzymatic antioxidants (Di Meo et al., 2016). This machinery plays a dual role: it facilitates essential redox signaling for cell growth and immune responses, but its dysregulation leads to oxidative stress, a key driver of cancer, neurodegeneration, and cardiovascular disease (Sies & Jones, 2020). Pharmacological intervention typically focuses on inhibiting specific ROS-generating enzymes or enhancing the capacity of the antioxidant handling system to restore redox homeostasis. Consequently, this machinery is a major focus for drug development in chronic inflammatory and age-related conditions. Therapeutic challenges include the need for precise targeting to avoid disrupting physiological ROS signaling required for normal cellular function (Di Meo et al., 2016).
Modulation of cellular redox state through the targeted inhibition of ROS-producing enzymes (e.g., NOX inhibitors) or the pharmacological augmentation of antioxidant defense mechanisms (e.g., SOD mimetics and glutathione precursors) to mitigate oxidative damage.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation and handling machinery (ROS machinery).